Topic
Addiction medicine
About: Addiction medicine is a research topic. Over the lifetime, 1070 publications have been published within this topic receiving 23685 citations.
Papers published on a yearly basis
Papers
More filters
01 Jan 1999
TL;DR: In this paper, the authors discuss advocacy and empowerment as ways to improve an incarcerated woman's life and discuss critical issues concerning advocating for change in public policy, including the role of advocate and empowerment.
Abstract: Currently, women represent 30 percent of the drug-abusing population but are entering the prison system at a rate two times that of men. How can practitioners meet the pressing needs of offender women in treatment, prisons, and jails through the 1990s and the millennium? The correctional environment poses special advocacy challenges. The role of advocate can no longer be performed by any single entity. As advocates for quality service delivery, counselors and providers of care must collaborate with clients and others advocating for changes in public policy. Advocacy involves clients, their families, and the community. This paper discusses advocacy and empowerment as ways to improve an incarcerated woman's life. Eleven critical issues concerning advocating for change in public policy are listed. Advocates are encouraged to inform the public and legislators about the problems related to addiction treatment for incarcerated women and about appropriate solutions. (Contains 3 references.) (MKA) Reproductions supplied by EDRS are the best that can be made from the original document.
2 citations
TL;DR: The article finds that while the Final Rule on MAT was a step in the right direction, it does not go far enough to adequately address the epidemic and proposes practical recommendations for increasing patient access to treatment for OUDs.
Abstract: According to the Substance Abuse and Mental Health Services Administration, 2.4 million individuals have an opioid use disorder (OUD). Yet, nearly 80 percent of them-more than 1.9 million people-do not receive treatment. Medication-assisted treatment (MAT), specifically with buprenorphine, has proven to be effective in treating patients with OUDs while also reducing costs to the healthcare system, criminal justice system, and workforce. Despite its effectiveness, barriers to MAT continue to exist. Consequently, many individuals must wait months, if not years, to receive treatment. This article analyzes the US Department of Health and Human Services' final rule (Final Rule) on MAT, common barriers to treatment, and the cost-benefit of treatment in light of the current opioid abuse epidemic. The article finds that while the Final Rule was a step in the right direction, it does not go far enough to adequately address the epidemic. Finally, the article proposes practical recommendations for increasing patient access to treatment for OUDs, including increasing the patient limit for highly qualified addiction treatment providers so that they can practice addiction medicine on a full-time basis and exempting buprenorphine products labeled by the US Food and Drug Administration for direct administration from the practitioner's patient limit.
2 citations
TL;DR: Internet addiction treatment experts highlight the existence and severity of Internet addiction as psychopathology requiring professional therapy, and should be taken seriously not to marginalise those affected.
2 citations
Journal Article•
TL;DR: The purpose of this review is to seek answers to postulates about lofexidine's role in the management of withdrawal by using evidence-based testimony.
Abstract: Is there any evidence that lofexidine is as effective as and better tolerated than clonidine for opiate detoxification? Could lofexidine be safely combined with other agents in the management of withdrawal? The purpose of this review is to seek answers to these postulates by using evidence-based testimony.
2 citations